Episode 1: Human Monoclonal Antibody Discovery for Infectious Diseases
Fill out the form below, and we shall send your colleague an invitation to the "Episode 1: Human Monoclonal Antibody Discovery for Infectious Diseases" event.
Epidemic viral outbreaks are increasing in frequency, driving demand for rapid and effective countermeasures. Human monoclonal antibodies have emerged as critical tools for prevention and treatment, but their success depends on identifying high-quality candidates quickly and precisely.
In this on-demand presentation from Episode 1 of the Therapeutic Antibody Series 2026, explore the latest advances in antibody discovery and the key principles guiding lead candidate selection for clinical development. Learn how next-generation platforms are accelerating discovery, improving precision and enabling the identification of more promising therapeutic candidates.
Complete the form to access this on-demand presentation and all other episodes in the series.
- Discover how single-cell and AI-based approaches improve candidate identification
- Understand the role of advanced screening platforms in accelerating hit discovery
- Learn how next-generation tools enhance developability and lead quality